{"pageContent": "Purpose: Research on prostate cancer and quality of life (QOL) has focused on the effects of treatment type on subsequent QOL, without considering effects of depressive symptoms. The present purpose is to test the independent contribution of depressive symptoms (measured within 4 weeks after treatment) and treatment type in predicting QOL measured 4, 7, and 12 months following treatment for clinically localized prostate cancer.", "metaData": {"source": "Is time from diagnosis to radical prostatectomy associated with oncological outcomes?\nhttps://pubmed.ncbi.nlm.nih.gov/30483947/"}}